NO912391D0 - Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene. - Google Patents

Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene.

Info

Publication number: NO912391D0
Authority: NO; Norway
Prior art keywords: infections; prophylactic; therapeutic; organizations; breathing
Prior art date: 1989-10-30

Application number

NO912391A

Other languages

English (en)

Norwegian (no)

Other versions

NO912391L (no

Inventor

Bengt Andersson

Gustaf Aniansson

Ragnar Lindstedt

Catharina Eden Svanborg

Original Assignee

Bengt Andersson

Gustaf Aniansson

Ragnar Lindstedt

Catharina Eden Svanborg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-30

Filing date

1991-06-19

Publication date

1991-06-19

1991-06-19 Application filed by Bengt Andersson, Gustaf Aniansson, Ragnar Lindstedt, Catharina Eden Svanborg filed Critical Bengt Andersson

1991-06-19 Publication of NO912391D0 publication Critical patent/NO912391D0/no

1991-06-19 Publication of NO912391L publication Critical patent/NO912391L/no

Links

208000015181 infectious disease Diseases 0.000 title abstract 3
230000000069 prophylactic effect Effects 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
230000029058 respiratory gaseous exchange Effects 0.000 title 1
235000013336 milk Nutrition 0.000 abstract 2
210000004080 milk Anatomy 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
241000606768 Haemophilus influenzae Species 0.000 abstract 1
239000005018 casein Substances 0.000 abstract 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
235000021240 caseins Nutrition 0.000 abstract 1
235000020256 human milk Nutrition 0.000 abstract 1
210000004251 human milk Anatomy 0.000 abstract 1
239000008267 milk Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
210000002345 respiratory system Anatomy 0.000 abstract 1
239000000758 substrate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/202—Casein or caseinates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Pulmonology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Virology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Housing For Livestock And Birds (AREA)

NO91912391A 1989-10-30 1991-06-19 Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene. NO912391L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE8903625A SE465109B (sv)	1989-10-30	1989-10-30	Antibakteriell komposition
PCT/SE1990/000702 WO1991006308A1 (fr)	1989-10-30	1990-10-30	Fraction de caseine a usage therapeutique, prophylactique et/ou diagnostique dans des infections des voies respiratoires

Publications (2)

Publication Number	Publication Date
NO912391D0 true NO912391D0 (no)	1991-06-19
NO912391L NO912391L (no)	1991-06-19

Family

ID=20377332

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO91912391A NO912391L (no)	1989-10-30	1991-06-19	Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene.

Country Status (15)

Country	Link
EP (1)	EP0454813B1 (fr)
JP (1)	JPH04503077A (fr)
KR (1)	KR920700678A (fr)
AT (1)	ATE170754T1 (fr)
AU (1)	AU633647B2 (fr)
CA (1)	CA2044244A1 (fr)
DE (1)	DE69032646T2 (fr)
DK (1)	DK0454813T3 (fr)
ES (1)	ES2121755T3 (fr)
FI (1)	FI102516B (fr)
HU (1)	HU212935B (fr)
NO (1)	NO912391L (fr)
RU (1)	RU2035913C1 (fr)
SE (1)	SE465109B (fr)
WO (1)	WO1991006308A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5538952A (en) *	1994-05-26	1996-07-23	Abbott Laboratories	Inhibition of infection of mammalian cells by respiratory syncytial virus
US5506209A (en) *	1994-05-26	1996-04-09	Abbott Laboratories	Product for inhibition of infection of mammalian cells by respiratory syncytial virus
WO1995032727A1 (fr) *	1994-05-26	1995-12-07	Abbott Laboratories	Inhibition de l'infection de cellules de mammiferes par le virus respiratoire syncytial
US5707968A (en) *	1994-05-26	1998-01-13	Abbott Laboratories	Inhibition of attachment of H.influenzae to human cells
US5643880A (en) *	1994-05-26	1997-07-01	Abbott Laboratories	Product for inhibition of attachment of H. influenzae to human cells
EP0760673A1 (fr) *	1994-05-26	1997-03-12	Abbott Laboratories	INHIBITION DE LA FIXATION DE $i(H. INFLUENZAE) SUR DES CELLULES HUMAINES
US5942254A (en) *	1995-02-27	1999-08-24	Abbott Laboratories	Phosphorylated recombinant human β-casein expressed in a bacterial system
EP0862450A2 (fr) *	1995-11-06	1998-09-09	Abbott Laboratories	Procede permettant d'inhiber la fixation de h. influenzae sur des cellules humaines a l'aide de beta-caseine humaine phosphorylee de recombinaison
AU1158197A (en) *	1995-11-06	1997-08-11	Abbott Laboratories	Product for inhibition of attachment of h. influenzae to human cells
AUPP494798A0 (en)	1998-07-29	1998-08-20	Pacific Biolink Pty Limited	Protective protein formulation
RU2346694C2 (ru) *	2002-11-26	2009-02-20	Дзе Юниверсити Оф Чикаго	Вещества и способы для профилактики и лечения опосредованных микроорганизмами эпителиальных нарушений
BR0215954A (pt)	2002-11-26	2005-09-13	Uc Tech	Métodos de redução da possibilidade de mortalidade em um animal, de expressão virulenta em um patógeno intestinal, e da expressão de adesina / lectina pa-i em uma célula bacteriana, de inibição de expressão de adesina / lectina pa-i em um patógeno intestinal, de ativação induzida por intestino de adesina / lectina pa-i, de mudança morfológica induzida por c4-hsl de um patógeno intestinal, e de aderência de célula bacteriana em um intestino de mamìfero, de melhoria de patogênese intestinal, de prevenção de uma doença ou condição anormal, de infecção de pele e respiratória, de uma doença sexualmente transmitida, de um distúrbio de trato digestivo, de perda de capacidade lactante em um animal, e de desenvolvimento de um distúrbio epitelial mediado por micróbio em uma animal de idade de amamentação, de irrigação de pelo menos uma porção do trato urinário, e para monitoração da administração de poli (etileno-glicol) (peg) a um animal, composição farmacêutica, kits para a prevenção ou tratamento terapêutico de sepsia derivada de intestino, e para a monitoração da administração de poli (etileno-glicol), e, preservativo
JP5702601B2 (ja) *	2007-07-06	2015-04-15	ラクレード，インコーポレーテッド	気道中の生物膜を溶解するための加水分解酵素および酸化酵素の使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1496671A (en) *	1975-03-27	1977-12-30	Grindstedvaerket As	Anti-cancer-active sour milk fraction
FR2491334A1 (fr) *	1980-10-03	1982-04-09	Inst Nat Sante Rech Med	Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2592769B1 (fr) *	1986-01-10	1990-10-12	Agronomique Inst Nat Rech	Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique
JP2631470B2 (ja) *	1987-05-15	1997-07-16	雪印乳業株式会社	感染防御剤

1989
- 1989-10-30 SE SE8903625A patent/SE465109B/sv not_active IP Right Cessation
1990
- 1990-10-30 DE DE69032646T patent/DE69032646T2/de not_active Expired - Fee Related
- 1990-10-30 AU AU66470/90A patent/AU633647B2/en not_active Ceased
- 1990-10-30 ES ES90916537T patent/ES2121755T3/es not_active Expired - Lifetime
- 1990-10-30 HU HU912203A patent/HU212935B/hu not_active IP Right Cessation
- 1990-10-30 DK DK90916537T patent/DK0454813T3/da active
- 1990-10-30 WO PCT/SE1990/000702 patent/WO1991006308A1/fr not_active Ceased
- 1990-10-30 JP JP2515465A patent/JPH04503077A/ja active Pending
- 1990-10-30 CA CA002044244A patent/CA2044244A1/fr not_active Abandoned
- 1990-10-30 AT AT90916537T patent/ATE170754T1/de not_active IP Right Cessation
- 1990-10-30 EP EP90916537A patent/EP0454813B1/fr not_active Expired - Lifetime
- 1990-10-30 KR KR1019910700615A patent/KR920700678A/ko not_active Ceased
1991
- 1991-06-19 NO NO91912391A patent/NO912391L/no unknown
- 1991-06-28 FI FI913154A patent/FI102516B/fi active
- 1991-06-28 RU SU914895868A patent/RU2035913C1/ru active

Also Published As

Publication number	Publication date
DE69032646T2 (de)	1999-05-27
WO1991006308A1 (fr)	1991-05-16
FI102516B1 (fi)	1998-12-31
FI102516B (fi)	1998-12-31
HU212935B (en)	1996-12-30
FI913154A0 (fi)	1991-06-28
AU6647090A (en)	1991-05-31
DE69032646D1 (de)	1998-10-15
JPH04503077A (ja)	1992-06-04
SE8903625D0 (sv)	1989-10-30
CA2044244A1 (fr)	1991-05-01
ATE170754T1 (de)	1998-09-15
SE465109B (sv)	1991-07-29
KR920700678A (ko)	1992-08-10
SE8903625L (sv)	1991-05-01
AU633647B2 (en)	1993-02-04
RU2035913C1 (ru)	1995-05-27
DK0454813T3 (da)	1999-02-01
ES2121755T3 (es)	1998-12-16
EP0454813A1 (fr)	1991-11-06
NO912391L (no)	1991-06-19
EP0454813B1 (fr)	1998-09-09

Publication	Publication Date	Title
NO912391L (no)	1991-06-19	Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene.
EP0909814A3 (fr)	2003-02-26	Utilisation de protéine kinases pour le diagnostic et le traitement de la Maladie d'Alzheimer
EP2261358A3 (fr)	2011-02-23	Antigènes de Streptococcus
ATE165395T1 (de)	1998-05-15	Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
BR0013814A (pt)	2002-04-23	Métodos de tratamentos de um paciente humano suscetìvel a ou diagnosticado com uma doença com anticorpos anti-erbb2, artigos industrializados, métodos de tratamentos de câncer em pacientes humanos e usos do anticorpo anti-erbb2
BR1101088A (pt)	2002-04-02	Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
DE3853854D1 (de)	1995-06-29	Vakzin gegen Neisseria meningitidis Gruppe-B, Gammaglobulin und Transferfaktor.
AP2000001886A0 (en)	2000-09-30	Group B streptococcus antigens.
MXPA03000103A (es)	2003-06-19	Antigenos de streptococcus.
GB9524934D0 (en)	1996-02-07	Treatment and diagnosis of infections due to helicobacter pylori
DE3788184D1 (de)	1993-12-23	Zahnärztliche Röntgendiagnostikeinrichtung zur Herstellung von Übersichtsaufnahmen von im Schädel verlaufenden Schichten.
ATE43500T1 (de)	1989-06-15	Herstellung von antikoerpern.
ES2136206T3 (es)	1999-11-16	Composicion antibacteriana que contiene alfalactalbumina multimerica.
WO1992021697A3 (fr)	1993-05-13	Peptides diagnostiques derives d'antigenes de la m.tuberculose
DE69002946D1 (de)	1993-09-30	Paracetamol enthaltende arzneizubereitung.
Rubin et al.	1968	Shigella sonnei osteomyelitis and sickle-cell anemia
Lai A Fat et al.	1974	The synthesis of secretory component by lymphoid tissues in vitro
ATE27822T1 (de)	1987-07-15	Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.
Winholt	1915	Complement-Fixation in Whooping Cough
NO20000694L (no)	2000-02-29	Fremgangsmåte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger
RU93032908A (ru)	1995-10-10	Способ получения мягкого сыра
Prescott	1913	Public health aspects of the candy industry
EP1950302A3 (fr)	2010-06-23	Nouveaux antigènes de streptocoque
ERNST	1891	Preliminary Report on the Clinical Use of Tuberculin
DE69016135D1 (de)	1995-03-02	Diagnostikgerät zur funktionellen Untersuchung des Kreislaufsystems.